Verona Pharma plc Total Liabilities

Latest as of June 2025: €294.60 Million EUR ≈ $344.42 Million USD

Verona Pharma plc total liabilities. Based on the latest financial reports, Verona Pharma plc (I9SA) has total liabilities worth €294.60 Million EUR (≈ $344.42 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See I9SA days of operational coverage to measure how many days the company can operate on defensive assets alone.

Total Liabilities of Verona Pharma plc (2016–2024)

Total liabilities of Verona Pharma plc from 2016 to 2024. This chart illustrates how Verona Pharma plc's total liabilities have evolved over time, based on quarterly financial data. Check I9SA asset liquidity ratio to evaluate the company's liquid asset resilience ratio.

Verona Pharma plc Competitors by Total Liabilities

The table below lists competitors of Verona Pharma plc ranked by their total liabilities.

Company	Country	Total Liabilities
Komercni Banka A.S. PR:KOMB	Czech Republic	Kč1.68 Trillion
Ningbo Deye Technology Co Ltd SHG:605117	China	CN¥9.19 Billion
Hella KGaA Hueck & Co XETRA:HLE	Germany	€4.17 Billion
Subsea 7 S.A F:SOCA	Germany	€3.85 Billion
Vietnam JSCmmercial Bank for Industry and Trade VN:CTG	Vietnam	₫2588.06 Trillion
FREEDOM HLDG DL-001 F:DMW2	Germany	€12.51 Billion
SpareBank 1 Sør-Norge ASA OL:SB1NO	Norway	Nkr491.18 Billion
TTM Technologies Inc NASDAQ:TTMI	USA	$1.12 Billion

Liability Composition Analysis (2016–2024)

This chart breaks down Verona Pharma plc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Verona Pharma plc asset portfolio.

Liquidity & Leverage Metrics

Verona Pharma plc Total Liabilities Ratios Explained

Verona Pharma plc total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	10.71	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	1.06	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.51	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Verona Pharma plc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Verona Pharma plc (2016–2024)

The table below shows the annual total liabilities of Verona Pharma plc from 2016 to 2024.

Year	Total Liabilities	Change
2024-12-31	€269.68 Million ≈ $315.29 Million	+358.32%
2023-12-31	€58.84 Million ≈ $68.79 Million	+102.89%
2022-12-31	€29.00 Million ≈ $33.91 Million	-24.83%
2021-12-31	€38.58 Million ≈ $45.11 Million	+99.37%
2020-12-31	€19.35 Million ≈ $22.62 Million	+30.96%
2019-12-31	€14.78 Million ≈ $17.28 Million	+2.81%
2018-12-31	€14.37 Million ≈ $16.80 Million	+10.52%
2017-12-31	€13.00 Million ≈ $15.20 Million	-9.71%
2016-12-31	€14.40 Million ≈ $16.84 Million	--

About Verona Pharma plc

F:I9SA Germany Biotechnology

Market Cap

$9.07 Billion

€7.76 Billion EUR

Market Cap Rank

#2345 Global

#490 in Germany

Share Price

€90.20

Change (1 day)

+0.00%

52-Week Range

€90.20 - €90.20

All Time High

€91.80